We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Provectus Pharmaceuticals Adds Seventh Center to Phase 2 Clinical Trial of PV-10

News   Dec 26, 2008

 
Provectus Pharmaceuticals Adds Seventh Center to Phase 2 Clinical Trial of PV-10
 
 
 

RELATED ARTICLES

5.1 Million Dollar Funding Boost for Blinding Retinal Conditions

News

A $5.1 million grant has been awarded from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.

READ MORE

Drug Could Sustain Oxygen-Starved Hearts

News

In new studies a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia. Unlike its experimental predecessors, the new drug does not appear to cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. Instead, the new drug delivers its precious oxygen cargo only to the tissues that need it most.

READ MORE

Immunotherapy Success for Triple-Negative Breast Cancer

News

New research has shown that by using a combination of immunotherapy and chemotherapy the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE